Feeds:
Posts
Comments

Posts Tagged ‘harmaceutical Business Intelligence (LPBI) Group’

Curation of Scientific Content @Leaders in Pharmaceutical Business Intelligence (LPBI) Group, Boston

Author: Aviva Lev-Ari, PhD, RN

 

Aviva Lev-Ari, PhD, RN is the Editor-in-Chief of the BioMed E-Series of Leaders in Pharmaceutical Business Intelligence (LPBI) Group, Boston

https://pharmaceuticalintelligence.com/biomed-e-books/

UPDATED on 4/5/2018

e-Scientific Publishing: The Competitive Advantage of a Powerhouse for Curation of Scientific Findings and Methodology Development for e-Scientific Publishing – LPBI Group, A Case in Point – Updated on 4/2/2018

https://pharmaceuticalintelligence.com/2017/06/20/e-scientific-publishing-the-competitive-advantage-of-a-powerhouse-for-curation-of-scientific-findings-and-methodology-development-for-e-scientific-publishing-lpbi-group-a-case-in-point/

 

Our Publication process involves the following steps:

Step #1:

Identification of EXPERTS, AUTHORS, WRITERS (EAWs)

https://pharmaceuticalintelligence.com/contributors-biographies/experts-authors-writers-eaws/

EXPERTS, AUTHORS, WRITERS (EAWs) CURATE ORIGINAL SCIENTIFIC ARTICLES

EXPERTS, AUTHORS, WRITERS (EAWs) REPORT on Scientific Breakthroughs or Agendas of Conferences of TIGHTEST relevance to our Journal domain of Expertise:

Our DOMAINS in Scientific Media

  1.  Pharmaceutical: Biologics, Small Molecules, Diagnostics
  2.  Life Sciences: Genomics and Cancer Biology

III.  Patient-centered Medicine: Focus on #1: Cardiovascular, #2: Cancer, #3: Physiology Metabolomics, Immunology

  1. Biomedicine, BioTech, and MedTech (Medical Devices)
  2.  HealthCare: Patient-centered Medicine and Personalized/Precision Medicine

Step #2:

Identification of EDITORS

https://pharmaceuticalintelligence.com/contributors-biographies/senior-editors/

EXPERTS Editors, — ONLY — Medical Doctors, PhDs, MD/PhDs, PharmDs — are creating a CREATIVE EXPERTISE DRIVEN electronic Table of Contents (eTOCs)ONE OF A KIND per each volume — NOT IN EXISTENCE ANYWHERE ON THE INTERNET — not derived from consultation with other textbooksnot in existence in any public domain source

Step #3:

ALL our articles adhere to the strictest REFERENCE CITATION AND SOURCE CITATION STANDARDS

Step #4:

We publish ALL our articles FIRST on

http://pharmaceuticalintelligence.com

eReadership on 8/11/2016 1,032,865

Step #5:

EXPERTS Editors of our e-Books, are ALL — Medical Doctors, PhDs, MD/PhDs, PharmDs — ONLY — these requirements fulfilled AND a substantial LIST OF PUBLICATIONS entitles EAWs to become Editors and are granted the level of privilege of editing the written articles of other EAWs – the role of Editors.

EXPERTS Editors of our e-Books, are ALL — Medical Doctors, PhDs, MD/PhDs, PharmDs — ONLY they SELECT ARTICLES FOR INCLUSION in e-Books from our Archived REPOSITORY

On 8/11/2016 the Web site statistics included the following data:

  • 4,815 Scientific Articles, 
  • 491 Research Categories (Journal Ontology), and 
  • 9,433 Scientific Tags
  • 7,261 Scientific COmments

Step #6:

All volumes are converted to .mobi format for KINDLE platform

Step #7: 

All converted volumes are PROOFREAD BY TWO EDITORS

Step #8:

Editor-in-Chief is the ONLY authority authorizing the UPLOAD to Amazon.com of a ready to be published e-Book

Thus, we have published EIGHT e-Books in MEDICINE and Life Sciences

WE ARE ON AMAZON.COM

http://www.amazon.com/dp/B00DINFFYC

http://www.amazon.com/dp/B018Q5MCN8

http://www.amazon.com/dp/B018PNHJ84

http://www.amazon.com/dp/B018DHBUO6

http://www.amazon.com/dp/B013RVYR2K

http://www.amazon.com/dp/B012BB0ZF0

http://www.amazon.com/dp/B019UM909A 

http://www.amazon.com/dp/B019VH97LU

SEVEN VOLUMES are forthcoming in 2016-2017:

https://pharmaceuticalintelligence.com/2016/04/24/new-e-book-titles-forthcoming-on-amazon-com-in-2016-from-lpbi-groups-biomed-e-series-forthcoming-cover-pages/

  • ALL our e-Books contain Expert driven eTOCs demonstrating an ORIGINAL thought process and represent the FRONTIER of the STATE of Science in every case.
  • ALL our e-Books comprise of articles published first on http://pharmaceuticalintelligence.com
  • EVERY article upon publication is CONNECTED by the Expert, Author Writer to the following channels of SOCIAL MEDIA

Our Channels on Social Media and Internet Presence include:

  • Our Journal +1,031,000 eReaders on 8/11/2016

http://pharmaceuticalintelligence.com

  • Aviva’s – +6000 BIOTECH followers on LinkedIn

http://www.linkedin.com/in/avivalevari

  • LPBI Group’s FaceBook Page

http://www.facebook.com/LeadersInPharmaceuticalBusinessIntelligence

  • LPBI Group’s Twitter Account

http://twitter.com/pharma_BI

  • Aviva Manages three Groups on LinkedIn

Cardiovascular Biotech & Pharma UK & US Networking Group

906 members

https://www.linkedin.com/groups/4357927

Leaders in Pharmaceutical Business Intelligence

336 members

https://www.linkedin.com/groups/4346921

Innovation in Israel

172 members

https://www.linkedin.com/groups/2987122

  • LPBI Group’s Company’s Page on LinedIn

https://www.linkedin.com/company/9325543?trk=tyah&trkInfo=clickedVertical%3Acompany%2CclickedEntityId%3A9325543%2Cidx%3A1-1-1%2CtarId%3A1439226813927%2Ctas%3ALeaders%20in%20Pharmaceutica

Lastly, please review,

Key Opinion Leader (KOL) – Aviva Lev-Ari, PhD, RN, as evidenced by

Curator: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2016/07/21/key-opinion-leader-kol-aviva-lev-ari-phd-rn-as-evidenced-by/

 

Read Full Post »

%d bloggers like this: